Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Identified in a human 8p amplicon, MFHAS1 is a potential oncogene whose expression is enhanced in some malignant fibrous histiocytomas (MFH). Zusätzlich bieten wir Ihnen und und viele weitere Produktgruppen zu diesem Protein an.
the results indicate that MFHAS1 suppresses TLR4 (zeige TLR4 ELISA Kits) signaling pathway through induction of PP2A (zeige PPP2R4 ELISA Kits) C subunit cytoplasm translocation and subsequent c-Jun (zeige JUN ELISA Kits) degradation, leading finally to decrease AP-1 (zeige FOSB ELISA Kits) activity and cytokines expression.
MASL1 expression is upregulated during primary human CD34 (zeige CD34 ELISA Kits)+ cell erythroid differentiation and is an abundant protein in human red blood cells.
aim of the review is to summarize the existing information on MASL1 and also to compile data that could be linked to MASL1 [review]
MFHAS1 regulates Toll (zeige TLR4 ELISA Kits)-like receptor (TLR)-dependent signaling.
MASL1, a candidate oncogene (zeige RAB1A ELISA Kits) found in amplification of 8p23.1, is translocated in an immunoblastic B-cell lymphoma cell line.
Identified in a human 8p amplicon, this gene is a potential oncogene whose expression is enhanced in some malignant fibrous histiocytomas (MFH). The primary structure of its product includes an ATP/GTP-binding site, three leucine zipper domains, and a leucine-rich tandem repeat, which are structural or functional elements for interactions among proteins related to the cell cycle, and which suggest that overexpression might be oncogenic with respect to MFH.
malignant fibrous histiocytoma amplified sequence 1
, malignant fibrous histiocytoma-amplified sequence 1 homolog
, MFH-amplified sequences with leucine-rich tandem repeats 1
, leucine rich repeat containing 65
, malignant fibrous histiocytoma-amplified sequence 1
, malignant fibrous histiocytoma-amplified sequence with leucine-rich tandem repeats 1